• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Import) Feedback Help Print
Registration No. 国药准字HJ20160660
Original Registration No. H20160660
Drug Name(Chinese) 吸入用硫酸沙丁胺醇溶液
Drug Name(English) Salbutamol Sulfate Inhalation Solution
Proprietary Name(Chinese) 万托林
Proprietary Name(English) 暂无权限
Drug Sandard Code(Chines) 86978470000489
Manufacturers(English) GlaxoSmithKline Australia Pty Ltd.
Production Address(English) 1061 Mountain Highway BORONIA VIC 3155 Australia
State(Chinese) 澳大利亚
State(English) Australia
Dosage Form 吸入溶液剂
Strength 2.5ml:5mg(以沙丁胺醇计)
Packaging 5瓶/盒
Date Issued 2021-11-02
Valid Until 2026-11-01
Category 化学药品